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Replication-dependent histone mRNAs are not polyadenylated but end in a conserved 26-nucleotide structure 
that contains a stem-loop. Much of the cell cycle regulation of histone mRNA is post-transcriptional and is 
mediated by the 3' end of histone mRNA. The stem-loop binding protein (SLBP) that binds the 3' end of 
histone mRNA is a candidate for the factor that participates in most, if not all, of the post-transcriptional 
regulatory events. We have cloned the cDNA for the SLBP from humans, mice, and frogs, using the recently 
developed yeast three-hybrid system. The human SLBP is a 31-kD protein and contains a novel RNA-binding 
domain, which has been mapped to a 73-amino-acid region of the protein. The cloned SLBP is the protein 
bound to the 3' end of histone mRNA as antibodies specific for the SLBP remove all specific binding activity 
from nuclear and polyribosomal extracts. These depleted extracts do not cleave histone pre-mRNA efficiently, 
demonstrating that the SLBP is required for efficient histone pre-mRNA processing. 
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Metazoan replication-dependent histone mRNAs are the 
only cellular mRNAs that do not have poly(A) tails, end- 
ing instead in a highly conserved stem-loop. Because the 
replication-dependent histone genes do not have introns, 
the only processing reaction required for the formation 
of mature histone mRNA is cleavage to form the 3' end. 
Processing of the 3' end of histone mRNA requires two 
cis elements, the stem-loop that interacts with a factor 
termed the hairpin binding factor (HBF) (Mowry and 
Steitz 1987a; Vasserot et al. 1989; Melin et al. 1992), and 
a purine-rich sequence located 9-14 nucleotides 3' of the 
stem-loop that binds the U7 small nuclear ribonucle- 
oprotein particle (snRNP) (Mowry and Steitz 1987b; Cot- 
ten et al. 1988; Soldati and Schiimperli 1988; Bond et al. 
1991). In addition to these two trans-acting factors, there 
is a heat-labile factor that has not been well character- 
ized (Gick et al. 1987). 
The expression of the replication-dependent histone 
mRNAs is tightly coupled with DNA replication, with 
significant amounts of histone mRNA present only in S 
phase. The concentrations of histone mRNA are regu- 
lated at both transcriptional and post-transcriptional 
steps (Sch~mperli 1986; Marzluff and Pandey 1988; 
4Corresponding author. 
Heintz 1991). The post-transcriptional regulation is di- 
rected by the 3' end of the histone mRNA (Stauber et al. 
1986), presumably through interactions with trans-act- 
ing factors. There is regulation at two post-transcrip- 
tional steps, processing of the 3' end of histone mRNA in 
the nucleus as cells progress from G1 to S phase (Gick et 
al. 1987; Stauber and Schfimperli 1988; Harris et al. 
1991) and rapid degradation of the histone mRNA in the 
cytoplasm as cells progress from the end of S phase to 
mitosis (Pandey and Marzluff 1987; Harris et al. 1991). 
Previously, we have described a protein, termed the 
stem-loop binding protein (SLBP), that is bound to the 3' 
end of histone mRNA in polyribosomes (Hanson et al. 
1996). The SLBP is also present in the nucleus and has 
been implicated in the 3' processing of histone mRNA, 
either as HBF or as a component of HBF (Dominski et al. 
1995). Thus, the SLBP is an example of a protein that 
may shuttle between the nucleus and the cytoplasm. Us- 
ing a yeast three-hybrid selection system for RNA-bind- 
ing proteins (SenGupta et al. 1996), we have cloned the 
cDNA for the SLBP from humans and frogs. The mam- 
malian SLBP is a 31-kD protein that is not related to 
other proteins in the data base and that contains a novel 
73-amino-acid RNA-binding domain. Using antibodies 
specific for the cloned SLBP we show it is the major 
protein that binds the 3' end of histone mRNA in both 
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the nucleus and the cytoplasm and that it is required for 
histone pre-mRNA processing. 
R e s u l t s  
The stem-loop at the 3' end of the histone mRNA is 
necessary for efficient 3' end formation in vivo (Pandey 
et al. 1994) and is necessary and sufficient for regulation 
of histone mRNA degradation (Pandey and Marzluff 
1987). We have detected a specific protein, termed SLBP, 
that interacts with the 3' end of histone mRNA. The 
SLBP is present in both nuclei and polyribosomes (Pan- 
dey et al. 1991; Williams and Marzluff 1995; Hanson et 
al. 1996), with most of the SLBP present in polyribo- 
somes, presumably as part of the histone mRNP {Hanson 
et al. 1996). The SLBP binds the stem-loop as a monomer 
(Hanson et al. 1996), requiring the 26 nucleotides at the 
3' end of histone mRNA for efficient binding {Williams 
and Marzluff 1995). The SLBP-RNA complex is ex- 
tremely stable, suggesting that the SLBP interacts with 
the histone pre-mRNA and then remains bound for the 
lifetime of the histone mRNA (Williams and Marzluff 
1995). Partly because of the low abundance of the SLBP, 
purification of sufficient SLBP for cloning the SLBP 
eDNA has not yet been possible {Hanson et al. 1996). 
Cloning of the SLBP 
Mary Wickens, Stan Fields, and coworkers have recently 
devised a three-hybrid screen, a variation of the yeast 
two-hybrid technology, for selecting RNA-binding pro- 
teins in yeast (SenGupta et al. 1996). Briefly, a vector 
expressing the lexA DNA-binding domain fused with the 
phage MS-2 protein was integrated into the yeast ge- 
nome. A vector expressing a hybrid RNA from the 
RNase P promoter was introduced into the yeast. This 
hybrid RNA contains the MS-2 protein-binding site and 
the target RNA sequence of interest, in this case the 
histone stem-loop. Finally, a library containing cDNAs 
fused to the Gal4 activation domain is introduced. Ex- 
pression of a fusion protein that interacts with the target 
RNA sequence will result in activation of transcription 
from promoters that bind the lexA-MS2 fusion protein 
(Fig. 1A). The SLBP is an excellent candidate for using 
this technology to select a specific RNA-binding protein, 
as the histone 3' stem-loop is present only in metazoans, 
the 8LBP binds to the stem-loop as a monomer {Hanson 
et al. 1996), and the complex is very stable (Williams and 
Marzluff 1995). 
A diagram of the strategy, adapted from Wickens and 
coworkers (SenGupta et al. 1996), is shown in Figure 1A. 
Two genes, his3 conferring resistance to aminotriazole 
and lacZ encoding f~-galactosidase, which will turn the 
colonies blue in the presence of X-Gal, will be activated 
by the Gal4 activation domain fused with a eDNA that 
binds specifically to the RNA "bait." The conserved 26- 
nucleotide sequence present at the 3' end of all metazoan 
histone mRNAs is shown in Figure lB. The structure of 
the RNA bait is shown in Figure 1C. We placed the his- 
tone stem-loop at the 3' end of the bait RNA, the posi- 
tion where it is found in mature histone mRNA, by ter- 
minating transcription from the RNase P promoter by 
RNA polymerase III with a run of 6 Ts after the ACCCA 
at the 3' end of the stem-loop bait. The sequence of the 
loop we used was UCUC, chosen to avoid a potential run 
of 4 Us in the RNA that might have served as a tran- 
scription termination site for RNA polymerase IU. A C at 
position 2 in the loop is present in some mammalian  
histone mRNAs {Taylor et al. 1986). As a secondary 
screen for potential clones encoding proteins that inter- 
Figure 1. Strategy for selection of clones 
containing the RNA-binding activity of the 
SLBP. (A) The yeast three-hybrid system. A 
diagram of the strategy for the yeast three- 
hybrid system adapted from Wickens and 
co-workers is shown (SenGupta et al. 1996). 
The lexA-MS-2 fusion protein binds to the 
MS2 RNA-binding site in the RNA and the 
Gal4-cDNA fusion binds to the target 
RNA resulting in activation of both the 
lacZ and his3 gene in the yeast. (B) The 
structure of the conserved histone mRNA 3' 
end. The conserved sequence at the 3' end of 
metazoan histone mRNAs is shown. The 
boxed nucleotides are the invariant nude- 
otides. (C) Structure of the "bait" RNA and 
mutant "bait" RNA. The two bait RNAs 
used in these experiments are shown. The 
histone stem-loop was placed at the 3' end 
of the wild-type (WT) bait RNA and the 
same sequence reversed was placed at the 3' 
end of the mutant (RM) bait. 
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act specifically wi th  this sequence, a mutan t  bait iden- 
tical wi th  the first one, except wi th  the stem-loop se- 
quence reversed, was constructed (Fig. 1C). This se- 
quence does not bind the SLBP (Williams and Marzluff 
1995). 
Libraries containing cDNA from HeLa cells and Xeno- 
pus oocytes fused wi th  the Gal-4 activation domain were 
transfected into yeast, and aminotriazole-resistant colo- 
nies were selected. Nineteen aminotriazole-resistant 
colonies were obtained from 2 x 106 transformants from 
HeLa cell cDNA. These colonies were then plated on 
indicator plates and the six blue colonies selected (Fig. 
2A). Plasmid DNA was prepared from each blue colony, 
rescued by transformation into Escherichia coli and the 
plasmid DNA was introduced into the yeast strain con- 
taining the reverse-stem bait RNA. Of the six blue col- 
onies, five did not activate the lacZ gene when the mu- 
tant s tem-loop was used as a bait (Fig. 2B). These five 
plasmids were independent clones of the same cDNA. 
Eighteen aminotriazole-resistant  colonies were obtained 
from 2 x 10  6 t ransformants from Xenopus cDNA. Ten of 
these also activated the lacZ gene. Seven of the ten did 
not activate the lacZ gene in the yeast strain containing 
the mutan t  stem-loop. These seven plasmids were inde- 
pendent clones of the same cDNA. The plasmids that 
gave blue colonies in the yeast strain containing the mu- 
tant s tem-loop probably expressed a fusion protein that 
bound either to the MS2 protein, to a region of the RNA 
Figure 2. Selection of yeast containing the human SLBP. {A) 
Representative yeast colonies selected for resistance to 5 mM 
aminotriazole were tested for their ability to activate [3-galac- 
tosidase specifically through the wild-type histone 3' end. The 
aminotriazole-resistant colonies were first tested for expression 
of [3-galactosidase (top). (B) The plasmid DNA was isolated from 
the blue colonies (Hl l, H8, X17, X13) and reintroduced into 
yeast strains containing the wild-type stem-loop (WT) or the 
mutant (RM) stem-loop sequence. Those plasmids (H11, X17) 
that gave blue colonies when they were introduced into the 
yeast carrying the WT stem-loop and white colonies when in- 
troduced into yeast containing the mutant RM stem-loop en- 
coded the SLBP. 
bait that did not include the stem-loop, or directly to the 
DNA. These clones have not been characterized further. 
One of the h u m a n  cDNA clones contained a 1.7-kb 
insert starting 5' of the init iator ATG and ending in a 
poly(A) tail (Fig. 3A). Comparison of this sequence with 
the data base revealed that the complete h u m a n  cDNA 
was included in overlapping cosmids HDAB, HDAC, and 
DHAD from h u m a n  chromosome 4p16.3 (McCombie et 
al. 1992). This region, spanning 20 kb, containing eight 
exons, had been sequenced as part of the search for the 
Huntington's  disease gene (McCombie et al. 1992}. The 
exon-intron boundaries are indicated in Figure 3A. Ad- 
ditional cDNA clones were isolated by screening a phage 
library, and six phage were isolated that encoded the 
same mRNA, but none extended further than the largest 
insert from the yeast screen. The complete h u m a n  SLBP 
contains 269 amino acids (Fig. 3A) wi th  a predicted mo- 
lecular mass of 31 kD, significantly smaller  than the 45 
kD estimated for the SLBP by SDS-gel electrophoresis 
(Pandey et al. 1991; Hanson et al. 1996). The reason for 
this discrepancy is discussed below. 
We also cloned the mouse SLBP by screening a phage 
cDNA library with the h u m a n  SLBP insert. Five phage 
were obtained, all encoding different parts of the same 
cDNA. The longest insert, 1.6 kb, contained a near full- 
length cDNA clone. The 5' ends of the h u m a n  gene and 
the mouse and h u m a n  cDNAs are compared in Figure 
3B. Many of the h u m a n  clones isolated in the yeast 
three-hybrid screen were cloned upstream of the methi-  
onine that we designated as the initiator methionine,  
adding additional amino acids from translation of the 5' 
untranslated region of the h u m a n  SLBP m R N A  to the 
fusion protein. Inspection of the h u m a n  genomic se- 
quence reveals a stop codon in the same frame as the 
proposed initiator methionine,  just 5' of the longest 
cDNA clone obtained. In addition there is a candidate for 
a TATAA box 35 nucleotides from the start of the long- 
est h u m a n  cDNA clone. Comparison of the 5' end of the 
mouse and human  SLBP sequences shows that the two 
sequences are quite different starting immedia te ly  5' of 
the ATG, with numerous  subst i tut ions and potential  in- 
sertions and deletions. There is also a stop codon in the 
5' UTR in the same reading frame as the proposed initi- 
ator methionine  of the mouse SLBP m R N A  only 39 nu- 
cleotides 5' of the ATG codon. Taken together these ob- 
servations identify this ATG as the start codon for the 
SLBP. 
All the frog clones that specifically bound the s t em-  
loop encoded the same polypeptide, and this is clearly 
the homolog of the h u m a n  SLBP. Again there were fu- 
sion proteins identified in the yeast that included some 
amino acids from the 5' UTR in some of the frog clones 
(not shown). The sequences of the human,  mouse, and 
frog SLBP proteins are compared in Figure 3C. The hu- 
man  and mouse cDNAs encode proteins wi th  89% iden- 
tity (94% similarity), wi th  the mouse SLBP containing 
274 amino acids, attributable to a 5-amino-acid insertion 
near the carboxyl terminus.  The frog SLBP is 253 amino 
acids long and is 64% identical  (82% similar) wi th  the 
mouse and 60% identical  [78% s imi la r )wi th  the human  
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-i19 CGCCGGCQCGGGGACGCGGGTTTCTGCCTCAGGCCCTGCCCTGCTCTAC TCTGCGCTCT 
-68 CTGCCCGCGCCGCCGCCGCCTCAGCCTCGGCCCTGCGCTGCGCGCCCGGCCCGTGCTGCC 
1 A~ ~C ~ CGC CCG CG~. AGC CCG CCG &~ CAT CAG &GC C~ 
"46 GGT (~kC GCC AGC CCG CCG TCC C C GCG CGA AGC CTG GGA 
D G D A S p p S P A R W S L G 
91 CGG AAG CGC AGA GCC GAC GGC AGG CGC TGG AGG CCC GAA GAC GCC 
R K R R A D G R R W R P E D A 
136 GAG GAG GCA GAG CAC CGC GGC GCC GAG CGC AGA CCC GAG AGC TTT 
E E A E H R G A E R R P E S 
181 ACC ACT CCT (~%A GGC CCT AAA CCC CGT TCC AGA TGC TCT GAC 
T T P g G p K P R S R C S D W 
226 GCA AGT GCA GTT GAA GAA GAT GAA ATG AGG ACC AGA GTT AAC AAA 
A 9 A V 9 E D -- M R T R V N K 
271 GLKA A~ GCA AGA TAT AAA AGG AAA TC C CTC ATC AAT GAC TTT GGA 
]J M A R Y K R Kr L L I N D F G 
316 AGA GAG AGA AAA TCA TCA TCA GGA AGT TCT CAT TCA AAG GAG TCT 
R E R K S S S G S S D S K E S 
T P F E S L 
406 ATG AGG AGA CAG AAG CAG ATC AAC TAT GGG AAG AAC ACA ATT GCC 
M R R O K Q I N Y G K N T I A 
451 TAC CAT CGT TAT ATT AAA GAA GTC CCA AGA CAC CTT CGA CAA CCT 
Y D R Y I K E V P R H L R Q P 
496 GGC ATT CAT CCC AAG ACC CCT AAT AAA TTT AAG AAG TAT AGT CGA 
G I H P K T P N K F K K Y S R 
586 TTT TGG GAT CCT CCA GCG GAA GAA GGA TGT GAT TTG CAA GAA ATA 
F W D P P A E E G C D L Q E I 
631 CAC CCT GTA GAC CTT GAA TCT GCA GAA AGC AGC TCC GAG CCC CAG 
. 9 v o , . d  9 ~ - +  + 9 9 , ~ 
676 ACC ~ ~CT CAG CAT C ~ GAT G TAC TCT GGC A A CCC A C 
T 8 S O D D F D V Y S G T P T 
721 AAG GTG AGA CAC ATG GAC AGT CAA GTG GAG GAT GAG TTT GAT TTG 
K V R H M D S Q V E D E F D L 
766 GAA GCT TGT TTA ACT GAA CCC TTG AGA GAC TTC TCA GCC ATG AGC 
E A C L T E P L R D F S A M S 
811 TAA CTGCCCCCTGGCGGCCAGGAAGAGAAACAGCTCCTCCCCGACTAGGTGGAAGGC 
TGGCCAGGCACCAAGCATGTGTGTGCACTTGTACCTGGTGGTTTCTCTGTTAGCAGTC CA 
TTAGCTCATGCTGAATTATTTTTGCCTTACTTTCTTAAGAAACATTAATTTTATGTATAG 
TG AGTATATTTTGC ATGTTTTAAATTG TAAATGGAG C TAAGTC C AAGAAAGTAC TTGAAG 
CTCTCTTCCAGCGAGCTTAATTGCGTAATC CCTGTTGTCCTCCAC, C4~TAAGCTGACACGT 
CTACATAACTGGTTTTCCACAGGCATCTTCAGTTATTGCTTGTCAGGTGGACTGTTTTGG 
ATTTAACCATGTAATCCATGGGACCAATTGAGAGTCAGCTACTTTTATAGGCATCAAAGT 
ATTC TC AGACAC C TTTAATATC TTTATGG AAAC TTAA%~'q~ C C TTTTA TC AATATG T 
CATAACAGCATTCTGAAGTCAGACATTGTTAAATTGAGCTATTAAACTAATGAGTTTTAT 









Figure 3. Sequence of the human, mouse, and frog 
SLBPs. (A) The sequence of the longest human SLBP 
cDNA is shown, together with the predicted amino 
acid sequence of the human SLBP. Exons are shown by 
alternating bold and normal print. The polyadenyla- 
tion signal is shown in bold and underlined. (B) The 5' 
end of the human SLBP genomic sequence (McCombie 
et al. 1992) extending from the presumed promoter to 
the initiator ATG codon is shown. The putative 







M A C R P 
-42 CGCCTCA GC CTCGGCCCTGCGCTGCGCGCCCGGCCCGTGCTGCC ATG GCC TGC CGC CCG 
-44 CGAG~.~z~AGTGCTTGCCGCCGAGCTGCCCTTCAGACTTCTGCCGCC ATG GCC TGC AGA CCT 
** . * ** . . * . . 9 ** . 9 *** 9 . , , 
1 
MACRPRSPPRHQSRCDGDASPPSPARWSLGRKRRADGRRWRPED 43 
******** ** ** *** **************** _*** 
MACRPRSPPGYGSRRDGGASPRSPARWSLGRKRRADGRDRKPED 43 
._ . _._*** **** _**_ _ _* 
MSDHWRTISEEHR PHAPSRWSQGRKRCSDGKLRRHDDTDST 40 
H AEEAEHRGAER RPESFTTPEGPKPRSRCSDWASAVEEDE MRTRVNK 89 
_**_. ._ ********** ***************** ******* 
M SEEGELQTADH RPESFTTPEGHKPRSRCSDWASAVEEDE MRTRVNK 89 
_ _ _ **_******_*** _** **_******* _. _*_ 
X VFDTKPSEEPQARPDSFTTPESHKPVARCKDWGSAVEEDEQLREKVDQ 88 
H EMARYKRKLLINDFGR ERKSSSGSSDSKESMSTVPADFETDESVLMR 136 
*_************** ****************_****_********* 
M EIARYKRKLLINDFGR ERKSSSGSSDSKESMSSVPADVETDESVLMR 136 
_****_******_*** **_*********_. . ___*** _._ . 
X DIARYRRKLLINEFGRRERRSSSGSSDSKDS STHGEMETDPAVITR 134 
H RQKQINYGKNTIAYDRYIKEVPRHLRQPGIHPKTPNKFKKYSRRSWDQ 184 
********************************_*************** 
M RQKQINYGKNTIAYDRYIKEVPRHLRQPGIHPRTPNKFKKYSRRSWDQ 184 
******************* ******_. _****************** 
X RQKQINYGKNTIAYDRYIKAVPRHLREPNVHPRTPNKFKKYSRRSWDQ 182 
H QIKLWKVALHFWDPPAEEGCDLQEIHPVDLESAE SSSEPQTSS 228 
************************* **** . **** **** 
M QIKLWKVALHFWDPPAEEGCDLQEIQPVDLGEMETEFTESSSESQTSS 233 
**_**__*** ***** **_*** _ *_ __* *** 
X QIRLWRIALHQWDPPAAEGSDLQPFMEEDMVCTE TSS 219 
H QDDFDVYSGTPTKVRHMDSQVEDEFDLEACLTEPLRDFSAMS 269 
**_****_********_*_****************_****** 
M QDNFDVYAGTPTKVRHVDCQVEDEFDLEACLTEPLKDFSAMS 274 
9 _. ___******* .__ _._****_*_ . 
X QEN LFTGTPTKVRKVEA DDAFDLEPCFIEEELLS 253 
codons are underlined, and the putative Sp 1-binding sites in the proximal promoter are double-underlined. The sequence of the longest 
mouse cDNA obtained is aligned with the human SLBP sequence. The asterisks indicate the differences between the mouse and 
human sequence. {C) The predicted protein sequences from the human, mouse, and frog SLBP cDNAs are compared. Identical amino 
acids are marked with an asterisk and similar amino acids with a dash. The minimal  73-amino-acid RNA-binding domain is overlined.. 
SLBP. There is significant homology between the frog 
and mammalian proteins over most of their length, al- 
though the amino and carboxyl termini differ between 
the frog and mammalian SLBPs. The SLBP does not re- 
semble any other proteins in the data base, and in par- 
ticular does not contain any of the previously described 
RNA-binding domains (Burd and Dreyfuss 1994). The 
protein is not basic, with a predicted pI of 7.4, and con- 
tains similar amounts of aspartic and glutamic acid as 
lysine and arginine. 
The cloned SLBP binds specifically to the stem-loop 
Previously, the molecular mass of the mouse SLBP has 
been estimated at - 4 5  kD based on SDS-gel electropho- 
resis of UV cross-linked SLBP and Northwestern analysis 
of both polyribosomal and nuclear SLBP (Pandey et al. 
1991; Hanson et al. 1996). To determine whether the 
cloned SLBP was bound to the stem-loop, the human 
SLBP cDNA and several mutant human SLBP cDNAs 
with amino- and carboxy-terminal deletions (dia- 
grammed in Fig. 4AJ were transcribed with T7 RNA 
polymerase and the RNA was translated in a rabbit re- 
ticulocyte lysate {Fig. 4B). 
There was a major polypeptide with a mobility of 45 
kD synthesized in the reticulocyte lysate programmed 
with RNA transcribed from the SLBP cDNA {Fig. 4B, 
lane 1). A similar size was obtained when the human 
SLBP was synthesized in frog oocytes after injection of 
the mRNA or in a wheat germ translation system (not 
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shown). This mobility is consistent with the cloned 
cDNA representing the previously characterized SLBP 
(Pandey et al. 1991; Hanson et al. 1996), and suggests 
that the discrepancy in molecular mass is attributable to 
an anomalous mobility of the SLBP on SDS--polyacryl- 
amide gels (Fig. 4B, lane 1). Translation of the various 
deletion mutants gave the expected relative sizes, al- 
though all of these had slower mobilities than predicted 
from their molecular mass (Fig. 4B, lanes 2--6). In addi- 
tion to the major polypeptide, a minor polypeptide was 
produced from the full-length eDNA and the carboxy- 
terminal deletions. This polypeptide migrated slightly 
slower {-3-5 kD), suggesting that it may be a modified 
form of the SLBP (Fig. 4B, lanes 1-5). The modifications 
are presumably at the amino terminus as the amino- 
terminal deletions gave only a single component in the 
reticulocyte lysate (Fig. 4B, lane 6). 
The selection procedure used in yeast demonstrated 
that the cloned SLBP fusion protein interacted specifi- 
cally with the stem-loop in vivo. The fact that the same 
cDNA was recovered multiple times from two different 
species strongly supports the contention that this is the 
major polypeptide that recognizes specifically the stem- 
loop. To demonstrate whether the cloned protein binds 
the stem-loop specifically, we also performed a mobil- 
ity-shift assay with in vitro-translated SLBP. There was 
Figure 4. (See facing page for legend. ) 
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only a smal l  amount  of SLBP activity present in the re- 
t iculocyte lysate (Fig. 4C, lane 7). When the lysate was 
programmed wi th  RNA encoding the SLBP, the amount  
of SLBP as determined by the mobil i ty-shift  assay in- 
creased dramatical ly  (Fig. 4C, lane 3). The complex 
formed wi th  the in vitro-translated SLBP had a similar  
mobi l i ty  to the complex extracted from polyribosomes 
(Fig. 4C, lanes 2,3). 
The novel RNA-binding domain is a 73-amino-acid 
region 
To define further the sequences required for RNA bind- 
ing, we made amino- and carboxy-terminal deletions. A 
series of 3' deletions was constructed removing 13, 52, 
72, and 90 amino acids, respectively (Fig. 4A). These 
were all translated in the reticulocyte lysate giving prod- 
ucts consistent wi th  the expected reduced size of the 
deletions (Fig. 4B). The abili ty of each of these proteins to 
bind to the s tem-loop was assessed using the mobility- 
shift assay. Removal of 52 or 72 amino acids from the 
carboxyl terminus  did not affect binding to the RNA (Fig. 
4C, lanes 4,5), but removal of 90 amino acids abolished 
binding as measured by the mobili ty-shift  assay (Fig. 4C, 
lane 6; 4D, lane 8). Thus, the carboxy-terminal boundary 
of the RNA-binding site is between amino acids 179 
and 197. 
Removal of the first 16 amino acids did not affect the 
binding in vivo, as a clone wi th  these amino acids de- 
leted was selected in the yeast screen. Two additional 
amino terminal  deletions were analyzed. One deletion 
had the first 87 amino acids removed, and the other de- 
letion had amino acids 57-123 deleted. These clones 
were constructed from the gene wi th  the carboxy-termi- 
nal 13 amino acids deleted. All three of these truncated 
proteins bound the s tem-loop (Fig. 4D, lanes 5,6). A 
clone encoding the 110-amino-acid polypeptide (amino 
acids 88-197) was constructed and this small  polypep- 
tide synthesized in the reticulocyte lysate. This small  
polypeptide also bound specifically to the s tem-loop 
(Fig. 4D, lane 7). All of the deletion constructs formed 
similar  amounts  of complex wi th  the stem-loop, sug- 
gesting that the deletions bound to the s tem-loop wi th  
similar affinity. Both the binding of the full-length SLBP 
and the truncated SLBP were competed by the wild-type 
stem-loop IFig. 4E, lanes 3, 7) and were not competed by 
a mutan t  s tem-loop wi th  the s tem sequence reversed or 
by a nonspecific RNA (Fig. 4E, lanes 4,5 and 8,9). Thus, 
the 110-amino-acid fragment bound the RNA with  sim- 
ilar affinity and specificity as the full-length protein. 
A m i n i m a l  RNA-binding site of 73 amino acids ex- 
tending from amino acids 125 to 197 can be deduced 
from these data (Fig. 4A), and this m i n i m a l  73-amino- 
acid binding site is approximately equal in molecular  
mass to the 26-nucleotide RNA target. To demonstrate 
that this 73-amino-acid region is sufficient for specific 
binding to the stem-loop, we constructed a clone to ex- 
press only this portion of the SLBP. Because the small  
complex containing this polypeptide might  not be 
readily detected by a mobil i ty-shif t  assay, we attached 
five copies of a c-myc epitope tag to the amino  terminus 
of this polypeptide. We also attached the same tag to the 
complete SLBP. After programming the reticulocyte ly- 
sate with the "tagged" full-length SLBP mRNA, there 
was a larger complex detected that bound to the s t em-  
loop as judged by the mobil i ty-shif t  assay (Fig. 5A, lane 
3). This c-myc tagged protein, which  contains an addi- 
tional 73 amino acids at the amino terminal,  bound to 
the stem-loop (Fig. 5A, lane 3) and the complex was 
"shifted" by a c-myc antibody (Fig. 5A, lane 4). This re- 
sult demonstrates that the recombinant  protein syn- 
thesized in the reticulocyte lysate bound to the s t em-  
loop. 
The c-myc tagged 73-amino-acid polypeptide also 
bound specifically to the s tem-loop (Fig. 5B, lane 2). The 
complex was shifted by the anti-c-myc antibody (Fig. 5B, 
Figure 4. A 73-amino-acid region of the cloned SLBP encodes the RNA-binding domain. (A) A series of deletions were constructed to 
map the RNA-binding domain of the SLBP. The central black region is the deduced RNA-binding domain. The hatched regions are the 
amino- and carboxy-terminal regions that are not essential for RNA binding. The numbers refer to the amino acids deleted from the 
carboxyl (C) and amino (N) termini, respectively. (B) Translation of human SLBP and SLBP deletions in the reticulocyte lysate. The 
cloned DNAs were transcribed by T7 RNA polymerase and the RNA translated in the reticulocyte lysate for 90 min in the presence 
of [3SS]methionine. The products were analyzed by electrophoresis on 12% polyacrylamide gels and detected by autoradiography. (Lane 
1) Full-length SLBP; (lanes 2-5); SLBP truncated 13, 52, 72, or 90 amino acids from the carboxyl terminus; (lane 6) SLBP with the first 
87 and last 13 amino acids removed. (C) Binding of the stem-loop by the carboxy-terminal deletions of SLBP. Fifteen femtomoles of 
radiolabeled stem-loop (lane 1) was incubated with 5 ~g of the polyribosomal extract (lane 2) or with 12.5 ~1 of reticulocyte lysate 
programmed with RNA encoding the full-length (lane 3) or the carboxy-terminal deletion mutants (lanes 4-6). The mutants used are 
indicated above each lane. Lane 7 is incubation of 12.5 ~1 of the unprogrammed reticulocyte lysate with the probe. The arrow indicates 
the complex with full-length SLBP and NS indicates a nonspecific complex formed in the reticulocyte lysate. (D) Binding of amino- 
terminal deletions of the SLBP. Fifteen femtomoles of radiolabeled stem-loop (lane 1) was incubated with 5 ~g of the polyribosomal 
extract (lane 2) or with 12.5 ~1 of reticulocyte lysate programmed with RNA from the full-length (lane 3) or deletion mutants (lanes 
4-8). The mutants used are indicated above each lane. The position of the complex with full-length SLBP is indicated by the arrow. 
(E) A 110-amino-acid RNA-binding fragment of SLBP specifically binds the stem-loop. In lane 1 the probe was incubated with a nuclear 
extract. In vitro-translated full-length SLBP (lanes 2-5) and the 1 lO-amino-acid fragment A87NA72C (lanes 6-9) were incubated on ice 
for lO min with 15 femtomoles of labeled 30-nucleotide RNA containing the stem-loop. The complexes were resolved by electro- 
phoresis on a 10% polyacrylamide gel. In lanes 3 and 7, a 100-fold excess of the 30-nucleotide RNA was included, in lanes 4 and 8 a 
100-fold excess of an RNA with the stem sequence reversed was included, and in lanes 5 and 9 a 100-fold excess of a nonspecific RNA 
(AAAUACCUACUUCAUACAA) was included. The arrows indicate the specific complexes formed. The unbound probe has been run 
off the gel to allow good resolution of the complex with the 110-amino-acid protein. 
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Figure 5. A c -myc  tagged 73-amino-acid 
polypeptide binds the stem-loop specifi- 
cally. (A) The reticulocyte lysate was pro- 
grammed with a DNA encoding SLBP 
with five copies of a c-myc tag (73 amino 
acids) added to the amino terminus. The 
reticulocyte lysate (12.5 ~1) was incubated 
with 15 femtomoles of labeled probe (lanes 
3,4). Anti-c-myc antibody was then added 
to the reaction in lane 4. (Lane 1) Probe 
alone; (lane 2) the complex formed in a 
nuclear extract from mouse myeloma 
cells; (lane 5) incubation in unpro- 
grammed reticulocyte lysate. The bands 
labeled N and NM (myc-tagged) represent 
the specific complexes and bands labeled 
NS are the nonspecific complexes. (B) The 
reticulocyte lysate was programmed with 
cloned DNA encoding the A132NA72C 
polypeptide containing the five copies of 
the c-myc tag (lane I) or with the 
A124NA72C polypeptide containing five 
copies of the c-myc tag (lanes 2-5). The 
lysate was incubated with 15 femtomoles of labeled wild-type probe in the absence of competitor (lane 2), or in the presence of a 
100-fold excess of the wild-type stem-loop (lane 3), or the reverse-stem competitor {lane 4). One microliter of the c-rnyc antibody was 
added to the reaction in lane 5 after the incubation. Band N is the native SLBP present in low levels in the reticulocyte lysate and band 
N M is the complex with the myc-tagged polypeptide. 
lane 5) and was also competed by the wild-type compet- 
itor but not by the reverse-stem mutant  (Fig. 5B, lanes 
3,4). A c-myc tagged polypeptide with 8 additional amino 
acids deleted did not bind to the stem-loop as judged by 
the mobility-shift assay (Fig. 5B, lane 1). Thus, the amino 
terminal boundary of the RNA-binding domain is lo- 
cated near amino acid 125 and the 73-amino-acid region 
from amino acids 125 to 197 contains all the information 
necessary for specific binding to the stem-loop. This 73- 
amino-acid region also binds specifically to the s tem- 
loop RNA when it is expressed as a glutathionine 
S-transferase (GST) fusion protein in E. coli (L. Zheng, 
Z.-F. Wang, and W.F. Marzluff, unpubl.). 
This 73-amino-acid RNA-binding site (overlined in 
Fig. 3C) is - 2 0 %  lysine and arginine and is the most 
basic region of SLBP. Although the binding site is very 
conserved among the three vertebrate SLBPs, there are 
other equally conserved regions that are not essential for 
RNA binding, and these presumably mediate other func- 
tions of the SLBP (Fig. 3C). 
SLBP is the major protein that binds the stem-loop in 
nuclear and polyribosomal extracts 
To demonstrate conclusively that the cloned SLBP is the 
protein that we have detected previously in both nuclear 
and polyribosomal extracts, we generated antibodies di- 
rected against the carboxyl terminus of the cloned 
mouse SLBP using a 13-amino-acid synthetic peptide 
coupled to keyhole limpet hemocyanin. The antibodies 
were purified from the serum by chromatography on pro- 
tein A-Sepharose. The 26-nucleotide probe, containing 
the wild-type stem-loop, was incubated with a nuclear 
extract and then the antibody added. The antibody to the 
carboxyl terminus of the cloned SLBP shifted >95% of 
the complex (Fig. 6A, lane 5), whereas the preimmune 
serum and antibody directed against the carboxyl termi- 
nus of human cyclin D3 had no effect on the binding (Fig. 
6A, lanes 3,4). Addition of the 13-amino-acid carboxy- 
terminal peptide to the reaction prevented the supershift 
(Fig. 6A, lane 6). Similar results were found with the 
polyribosomal extract. The anti-SLBP shifted all the 
binding activity that was extracted from polyribosomes 
(Fig. 6B, lane 5), and again the binding of the antibody 
was competed by the synthetic peptide (Fig. 6B, lane 6). 
Thus, all the specific binding activity to the stem-loop 
in both the nuclear and polyribosomes detected using 
the mobility-shift assay is attributable to the SLBP that 
we have cloned. 
The antibody raised against the carboxy-terminal of 
SLBP was also tested by Western blotting on nuclear and 
polyribosomal extracts. The antibody specifically recog- 
nized two bands of - 4 5  and 40 kD in both the nuclear 
and polyribosomal extracts (Fig. 6C). The relative 
amounts of these two bands varied from extract to ex- 
tract and in many extracts the upper 45-kD band was 
predominant (cf. Fig. 6C with Fig. 7A). Binding of the 
antibody to both polypeptides was specific, and was 
competed by the carboxy-terminal peptide used for im- 
munization (Fig. 6C, lanes 5,6) but not by a peptide con- 
taining the first 15 amino acids of SLBP (Fig. 6C, lanes 
3,4). In the mobility-shift experiments it is common to 
see two closely spaced complexes (Fig. 4C-E and Fig. 6B), 
and it is possible that the two polypeptides represent 
different forms of SLBP that may form these two com- 
plexes. The two forms of SLBP could result either from 
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Figure 6. Antibody to the SLBP reacts with the major complex that binds the stem-loop. (A) Nuclear extract (15 ~g) was incubated 
with 15 femtomoles of the radiolabeled stem-loop. After incubation, 1 ~1 of anti-cyclin D3 antibody (lane 3), preimmune serum (lane 
4/, or anti-SLBP antibody Ilanes 5,6} was added to the reaction. In lane 6, 1 ~g of competitor carboxy-terminal peptide was also added. 
The specific complex is indicated by an arrow and NS is a nonspecific complex. The band labeled P is the probe (lane 1). (B) 
Polyribosomal extract was incubated with 15 femtomoles of the radiolabeled stem-loop. After incubation, 1 ~1 of anti-cyclin D3 
antibody (lane 3), preimmune serum (lane 4), or anti-SLBP antibody (lanes 5,6) was added to the reaction. In lane 6, 1 ~g of competitor 
carboxy-terminal peptide was also added. The specific complex is indicated by an arrow. (C) Fifty micrograms of protein from nuclear 
or polyribosomal extracts were resolved by electrophoresis on 10% SDS-polyacrylamide gels, transferred to nitrocellulose, and 
incubated with the anti-SLBP antibody in the absence (lanes 1,2) or presence of competitor synthetic peptide (1 ~g/ml) corresponding 
to the amino terminus (lanes 3,4) or carboxyl terminus (lanes 5,6) of SLBP. 
post-translational modification or from proteolysis (see 
Discussion}. 
Depletion of SLBP reduces the efficiency of histone 
pre-mRNA processing 
Histone pre-mRNA processing requires two defined 
trans-acting factors, U7 snRNP, which is absolutely re- 
quired for processing (Mowry and Steitz 1987b; Cotten et 
al. 1988) and HBF, which is not absolutely required for 
processing in vitro (Mowry et al. 1989; Streit et al. 1993). 
The degree of dependence of processing on HBF is vari- 
able with different extracts and with different substrates 
(Streit et al. 1993). Thus, addition of an RNA containing 
the stem-loop will reduce but not abolish processing 
(Streit et al. 1993; Dominski et al. 1995). Previously we 
showed by depleting a nuclear extract with a biotiny- 
lated RNA that HBF (and all the SLBP) could be removed 
from the extract resulting in a reduction in processing 
(Dominski et al. 1995). 
The anti-SLBP antibody was capable of depleting the 
binding activity from a nuclear extract. Aliquots of a 
nuclear extract were incubated with a protein A-Sepha- 
rose either after incubation with preimmune serum or 
with anti-SLBP antibody. The depleted extracts were 
then assayed for the presence of SLBP by Western blot- 
ting, the ability to bind the stem-loop, and the ability to 
process histone pre-mRNA. Both bands on the Western 
blot (45 kD and 40 kD) recognized in the nuclear extract 
by the anti-SLBP antibody were depleted specifically by 
the anti-SLBP antibody (Fig. 7A, lane 3), but not by the 
preimmune serum (Fig. 7A, lane 2). Similarly the binding 
activity was also removed from the extract depleted with 
the anti-SLBP antibody but not from the mock-depleted 
extract (Fig. 7B, lanes 4,5). Thus, essentially all of the 
SLBP, as detected by both Western blotting and the bind- 
ing assay, was removed from the extract. 
The ability of the nuclear extract and the depleted ex- 
tracts to process a synthetic 320-nucleotide histone pre- 
mRNA was determined. This extract had a strong depen- 
dence on the stem-loop, and processing was reduced 
-85% by the addition of excess wild-type stem-loop 
(Fig. 7C, lanes 2,3). Processing activity was slightly re- 
duced (25%) by mock depletion of the extract (Fig. 7C, 
lane 4), but was reduced significantly (fourfold) by deple- 
tion with the anti-SLBP antibody (Fig. 7C, lane 5). Re- 
moval of the SLBP with the antibody reduced processing 
to a similar extent as addition of the wild-type compet- 
itor RNA, indicating that the SLBP is a component of the 
processing machinery. 
These results are consistent with our previous result 
suggesting that the SLBP is, or is a component of, HBF 
(Dominski et al. 1995). We have not yet been able to 
restore processing to a depleted extract because of our 
inability to express active recombinant SLBP (see Dis- 
cussion). 
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We have cloned a novel RNA-binding protein, SLBP, 
from three vertebrate species, that binds specifically to 
the 3' end of histone mRNA. SLBP contains a small 
RNA-binding domain and is likely to be the critical 
trans-acting factor involved in many aspects of the me- 
tabolism of histone mRNA as well as the post-transcrip- 
tional regulation of histone mRNA during the cell cycle. 
It is clearly involved in the only processing reaction 
needed for histone mRNA biogenesis. 
Discussion 
The three-hybrid system devised by Wickens and co- 
workers (SenGupta et al. 1996} has the potential to allow 
isolation of rare RNA-binding proteins. The SLBP is an 
ideal candidate for using this technique, as the RNA tar- 
get sequence is small and well-defined and is not present 
in yeast RNA. In addition, the SLBP binds extremely 
tightly and stably to its target sequence {Williams and 
Marzluff 1995), increasing the likelihood that discrimi- 
nating conditions can be developed that would allow se- 
lection of positive clones. Indeed -80% of the positive 
clones from the initial screen (his + and blue) contained 
the SLBP. When these clones were reselected with a mu- 
tant stem-loop that does not bind SLBP, 100% of the 
clones that did not interact with the mutant  stem-loop 
contained the SLBP, and multiple independent clones 
were obtained from both the frog and human libraries, 
suggesting that the selection was very efficient. The 
other 20% presumably represent clones that encode gen- 
eral RNA-binding proteins, proteins that interact with 
the MS2 protein or that interact directly with the DNA. 
The same cDNA also has been isolated from a human 
library by Muller, Schfimperli, and coworkers (Martin et 
al. 1997) using this same system. They have demon- 
strated also that the cloned protein is involved in histone 
pre-mRNA processing by complementing an extract de- 
ficient in processing with the recombinant SLBP (Martin 
et al. 1997). 
The SLBP is a novel RNA-binding protein. A number 
of different types of RNA-binding domains have been 
identified in the past few years, and there are multiple 
examples of proteins with different binding specificities 
that are members of each of these classes (Burd and Drey- 
fuss 1994; Draper 1995). It is possible that there will be 
other RNA-binding proteins that have a similar RNA- 
binding domain as the SLBP but with different specific- 
ities. The 3' end of histone mRNA has been highly con- 
served in all metazoans and factors that interact with the 
stem-loop have been detected in all metazoans exam- 
ined so far, including Drosophila and sea urchins (T. 
Robertson, J. Howard and W.F. Marzluff, unpubl.). High- 
affinity binding of the SLBP requires the 26-nucleotide 
sequence at the 3' end of the histone mRNA, and mu- 
tagenesis experiments have indicated that the sequence 
of the stem is the most critical feature for high affinity 
binding (Williams and Marzluff 1995). It is likely that the 
SLBP is binding a particular novel three-dimensional 
structure assumed by the 3' end of histone mRNA. 
The sequence of the SLBP has been highly conserved 
between mammals and frogs. In addition to the con- 
served RNA-binding domain, which is expected, there is 
also extensive identity in the amino-terminal region be- 
tween amino acids 55 and 125, as well as in the carboxy- 
terminal region of the SLBP. These conserved amino acid 
sequences probably play a role in the various functions of 
SLBP in histone mRNA metabolism. 
We have shown here specifically that the SLBP we 
cloned is the major protein that binds to the 3' end of 
histone mRNA as detected by the RNA-binding assay. 
Using antibodies specific for the carboxyl terminus of 
the SLBP, we have demonstrated that the SLBP is the 
major binding activity present in both the nucleus and 
the polyribosomes, in agreement with our previous con- 
clusion that the same polypeptide functions in both 
compartments (Pandey et al. 1991; Dominski et al. 1995; 
Hanson et al. 1996). There are two forms of SLBP de- 
tected by Western blotting (Figs. 6C and 7A). We have 
observed that nuclear extracts containing predominantly 
the slower migrating form of SLBP are more active in 
histone pre-mRNA processing {Z. Dominski, unpubl.}. 
These two forms could result from post-translational 
modification of SLBP, and probably account for the fact 
that the complexes observed by mobility shift are often 
doublets (Fig. 4). Alternatively the faster migrating form 
could be a result of proteolysis from the amino terminus. 
When the antibody was used to remove SLBP from a 
nuclear extract {as assayed by Western blotting and mo- 
bility-shift assay) the depleted extract has a reduced abil- 
ity to process histone pre-mRNA, suggesting that SLBP 
is, or is a component of, the hairpin-binding factor, as we 
have suggested previously {Dominski et al. 1995). 
Although we have been successful in removing SLBP 
from the extract and reducing processing activity, we 
have not yet been successful in reconstituting processing 
with purified recombinant SLBP. Truncated forms of 
SLBP that are active in binding the stem-loop have been 
expressed in bacteria (L. Zhang and W.F. Marzluff, 
unpubl.) but because the full-length SLBP is toxic to bac- 
teria, we have not yet been able to prepare full-length 
active recombinant SLBP. 
The 3' end of mRNA is important in many aspects of 
mRNA metabolism. The poly(A) tail is necessary for ef- 
ficient translation of mRNAs (Jackson and Standart 
1990) and is important in determining the half-life of 
mRNAs (Bernstein and Ross 1989; Decker and Parker 
1994). The function of the poly(A) tail is mediated by the 
poly(A) binding protein (PABP) that is present as a com- 
ponent of the mRNP (Bemstein and Ross 1989). Simi- 
larly, the 3' end of histone mRNA is also necessary for 
efficient transport and translation of the mRNA (Sun et 
al. 1992; Williams et al. 1994), as well as being essential 
for regulation of histone mRNA half-life (Pandey and 
Marzluff 1987). Because the histone mRNA is degraded 
3' to 5', it is likely that SLBP (as part of the histone 
mRNP) plays a critical role in the degradation of histone 
mRNA. Unlike the PABP, the SLBP also participates in 
the nuclear metabolism of pre-mRNA, and is required 
for efficient histone pre-mRNA processing (Dominski 
et al. 1995). Thus, it joins a growing family of pro- 
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teins, inc luding  he te rogenous  nuc lear  r ibonucleopro-  
te in  (hnRNP) A1 (Pifiol-Roma and Dreyfuss  1992; 
Michael  et al. 1995) and rev  (Kalland et al. 1994), wh ich  
may  bind to p re -mRNA and then  accompany  the ma- 
ture m R N A  to the cytoplasm.  
Despi te  the s imi lar i t ies  in func t ion  in cy toplasmic  
m R N A  metabo l i sm be tween  SLBP and PABP, there  is no 
obvious sequence s imi la r i ty  be tween  these two proteins.  
The  PABP binds the  poly(A) tail  th rough  four RNP do- 
mains  (Nietfeld et al. 1990; Burd et al. 1991) and, in 
addit ion,  has a carboxy- terminal  doma in  presumably  re- 
sponsible for med ia t ing  o ther  func t ions  of the PABP 
through p ro t e in -p ro t e in  in terac t ions .  SLBP has a con- 
served central  doma in  tha t  is necessary  for R N A  binding. 
Extensive regions of the  amino  and carboxyl t e rmin i  of 
the SLBP are also conserved in ver tebra te  SLBPs, and we 
are current ly  inves t igat ing possible func t ions  for these 
conserved regions. SLBP is l ike ly  to be one of the  cri t ical  
t rans-act ing factors tha t  med ia t e  the  pos t - t ranscr ip t ional  
regulat ion of h i s tone  m R N A  levels, coupl ing  t hem 
t ight ly  to D N A  repl icat ion.  The  avai labi l i ty  of SLBP 
should al low the de t e rmina t i on  of the molecu la r  details 
of how the 3' end of h i s tone  m R N A  func t ions  in the 
various metabol ic  steps in h i s tone  m R N A  me tabo l i sm 
as wel l  as in  the pos t - t ranscr ip t ional  regula t ion  of his- 
tone m R N A  levels. 
Figure 7. Depletion of the SLBP from the nuclear extract re- 
duces processing efficiency. Nuclear extract was incubated ei- 
ther with preimmune serum (mock-depleted) or with anti-SLBP 
antibody and then passed over protein A-Sepharose. Aliquots of 
the extracts were then assayed for SLBP activity by Western 
blotting (A), mobility-shift (B), and processing of histone pre- 
mRNA (C). (A) Equal volumes of the nuclear extract (lane 1 ), the 
mock-depleted extract (lane 2), or the extract depleted with anti- 
SLBP (lane 3) were analyzed by Western blotting. The major 
polypeptide detected was the 45-kD polypeptide with a small 
amount of the 40-kD polypeptide in this extract. There was a 
small amount of rabbit IgG present in the depleted extracts 
(lanes 2,3), which is detected by the secondary antibody. (B) The 
extracts were assayed for binding activity using a 30-nucleotide 
probe and the mobility-shift assay. Five microliters (25 ~g) of 
the nuclear extract (lane 2), the mock-depleted extract (lane 4), 
or the anti-SLBP-depleted extract (lane 5) were incubated with 
the radiolabeled probe, and the complexes were resolved by na- 
tive gel electrophoresis. Lane 3 is nuclear extract in the presence 
of competitor wild-type RNA and lane 1 is the probe. N indi- 
cates the specific complex and P indicates the unbound probe. 
(C1 The extracts were assayed for ability to process a 320-nucle- 
otide histone pre-mRNA substrate. The pre-mRNA was incu- 
bated with 17jxl (85 ~g) of nuclear extract (lane 2), mock-de- 
pleted extract (lane 4), or extract depleted with the anti-SLBP 
antibody (lane 5). In lane 3, 1 txg of a 30-nucleotide wild-type 
stem-loop was added to the nuclear extract before the addition 
of the substrate. Lane 1 is the unprocessed substrate. RNA was 
purified from each reaction, analyzed by 7M urea-polyacryl- 
amide gel electrophoresis, and the products were detected by 
autoradiography. 
Materia ls  and m e t h o d s  
The three-hybrid screen 
The L40-coat strains and plasmids pMS2-1, and pIIIEx426RPR 
(SenGupta et al. 1996) were a gift of Dr. Mary Wickens (Univer- 
sity of Wisconsin). The plasmid pMS2-SLwT was constructed 
by digesting plasmid pMS2-1 with XmaIII and SpeI and inser- 
tion of a 39-nucleotide double-stranded oligonucleotide con- 
taining the wild-type stem-loop sequence and a RNA polymer- 
ase III termination site (see Fig. 1). The plasmid pIII/MS-SLwT 
was constructed by digesting the plasmid pMS2-SLwT with 
EcoRI and inserting the 170-nucleotide fragment into 
pIIIEx426RPR. The plasmid pMS2--SLgM was constructed by in- 
serting a double-stranded oligonucleotide containing the stem- 
loop with the sequence of the stem reversed (see Fig. 1B) and 
then the plasmid pIII/MS--SLRM was constructed by inserting 
the 170-nucleotide EcoRI fragment into pIIIEx426RPR. The 
proper orientation of the insert was confirmed by sequencing. 
Each of these plasmids was introduced into the yeast strain 
L40-coat by transformation and selection on ura- ,  trp- plates. 
The resulting yeast strains L40-coat/WT and L40-coat/RM 
were used in subsequent experiments. The HeLa cell two-hy- 
brid cDNA library cloned in pGAD-GH was a gift of Dr. Yue 
Xiong (University of North Carolina, Chapel Hill) and the Xe- 
nopus oocyte two-hybrid cDNA library cloned in pGAD10 was 
obtained from Clontech. Two hundred micrograms of plasmid 
DNA from each library was transformed into competent yeast 
L40-coat/WT cells as described by Clontech. The yeast were 
plated on leu-,  ura-,  trp-,  his-  plates containing 5 mM ami- 
notriazole. Nineteen aminotriazole-resistant colonies were ob- 
tained from 2 x 1 0  6 transformants from the HeLa cell cDNA. 
These colonies were then plated on indicator plates and the six 
blue colonies selected. Plasmid DNA was prepared from each 
blue colony, rescued by transfection into E. coli HB101 by se- 
lection on leu- plates, and the plasmid DNA was purified from 
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each colony. The plasmid DNA was then introduced into the 
yeast strain L40-coat/RM, which contained the plasmid pIII/ 
MS-SLy ,  encoding the reverse-stem bait RNA. Plasmids that 
did not activate the lacZ gene in strains containing the reverse- 
stem RNA as bait were sequenced. These plasmids (five from 
the human screen and seven from the Xenopus screen) were 
independent clones of the same cDNA. The full-length human 
SLBP cDNA was digested with EcoRI upstream of the initiator 
methionine and SpeI in the 3' untranslated region and cloned 
into pGEM3zf digested with EcoRI and XbaI for construction of 
the deletion mutants and transcription by T7 RNA polymerase. 
In vitro translation 
For in vitro translation the cloned DNA was linearized and then 
incubated in the TNT coupled transcription-translation retic- 
ulocyte lysate (Promega; 25-~1 reaction as described by the man- 
ufacturer) for 90 min. To visualize the protein product, 15-~1 
reactions containing 15 ~Ci of [35S]methionine were used and 
the reactions were analyzed by SDS--polyacrylamide gel electro- 
phoresis followed by autoradiography. For reactions that were 
used for the binding assays, the [3SS]methionine was omitted 
and a 1:1 mix of amino acids minus methionine plus amino 
acids minus leucine supplied by the manufacturer were used. 
Isolation of mouse SLBP cDNA and additional human SLBP 
cDNA clones 
A mouse cDNA library (kExLox( + ), Novagen) prepared from 
BB4 cells was screened using the 890-nucleotide fragment of the 
human SLBP containing the 5' end of the cDNA as a probe. Six 
phage were obtained, all encoding different parts of the same 
cDNA. The longest insert, 1.6-kb, contained a near full-length 
cDNA clone. Additional human cDNA clones were isolated by 
screening a cDNA library prepared from HeLa cell DNA with 
the same probe. All of the five positive phage obtained encoded 
the same eDNA as was isolated in the three-hybrid screen and 
none extended further 5' than the longest clone obtained from 
the yeast three-hybrid screen. The GenBank accession nos. for 
the human mouse, and Xenopus SLBP clones are U75679, 
U75680, and U75681, respectively. 
Construction of the deletion mutants 
The deletion mutants were constructed using restriction en- 
zyme sites in the human SLBP clone. Digestion with HindIII 
removed 13 amino acids, digestion with PstI removed 52 amino 
acids, digestion with BamHI removed 72 amino acids, and fi- 
nally, digestion with SalI removed 90 amino acids from the 
carboxyl terminus. For the amino terminal deletion of 87 amino 
acids, the gene truncated at HindIII was digested with NcoI at 
the initiator methionine and the NcoI site was filled in with the 
Klenow fragment of DNA polymerase I. The gene was then 
digested with HpaI removing a 260-nucleotide fragment and the 
resulting plasmid religated. To generate the deletion of amino 
acids 58-124, the gene truncated at HindIII was digested with 
AvaI {at amino acid 57) and with NaeI at amino acid 124. The 
DNA was incubated with the Klenow fragment of DNA poly- 
merase and deoxynucleotide triphosphates to fill in the AvaI 
overhang. The plasmid was then religated resulting in an in- 
frame deletion. 
To construct the dI87NA72C gene, the plasmid containing the 
A87N gene was digested with BamHI and HindIII to remove the 
carboxy-terminal region of the protein, the ends filled in with 
DNA polymerase and religated. For production of the myc- 
tagged SLBP, the mouse SLBP DNA was digested with ApaI in 
the polylinker 3' of the gene and the overhang was blunted with 
T4 DNA polymerase. The fragment containing the SLBP was 
excised subsequently with NcoI at the initiator methionine and 
ligated into plasmid MT6 {a gift of Mark Roth, Seattle), digested 
with NcoI between the fifth and sixth 11 amino acid myc tag in 
the vector. The A124N~72C and A132NA72C genes were con- 
structed by PCR using appropriate primers containing an NcoI 
site for the amino-terminal boundary. The PCR product was 
digested with NcoI/BamHI and the resulting fragment cloned 
into plasmid MT6, resulting in five copies of a c-myc tag on 
these polypeptides. 
Antisera 
A synthetic peptide corresponding to the last 13 amino acids of 
the mouse SLBP sequence was synthesized in the University of 
North Carolina (UNC) peptide synthesis facility and purified by 
reverse-phase HPLC. Ten milligrams of peptide was coupled to 
10 mg of keyhole limpet hemocyanin. The keyhole limpet 
hemocyanin-coupled peptide was injected into two rabbits and 
serum was collected after the second injection (Pocono Farms, 
PA). To purify the immunoglobulin, 0.5 ml of serum was passed 
over a 0.5-ml column of protein A-Sepharose, the column 
washed with 10 volumes of 100 mM Tris (pH 8.0), followed by 
10 volumes of 10 mM Tris {pH 8.0). The antibody was eluted 
with 100 mM glycine (pH 3.0), neutralized and stored at 4~ 
(Harlow and Lane 1988). As a control, an antihuman cyclin D3 
antibody raised against the carboxy-terminal peptide of mouse 
human cyclin D3 was used (a gift of Drs. Dawn Phelps and Yue 
Xiong). Western blots were performed by standard procedures 
{Harlow and Lane 1988). 
Mobility-shift assays 
Mobility-shift assays were performed using a radiolabeled 30- 
nucleotide stem-loop RNA prepared by transcription of oligo- 
nucleotide templates as described previously (Pandey et al. 
1991). Twenty-five microliters of reticulocyte lysate pro- 
grammed with the appropriate RNAs were used for the binding 
reactions. The lysates were mixed with 15 femtomoles of la- 
beled RNA probe and 25 ~1 of buffer [10% glycerol, 5 mM 
Mg(OAc)2, 20 mM triethanolamine {pH 7.8), 10 mM KC1, 0.5 
mg/ml of BSA, 0.5 mg/ml of yeast tRNA, 20 mM EDTA, and 2 
mM dithiothreitol] and incubated on ice for 10 min followed by 
a 5-rain incubation at room temperature. The reactions were 
analyzed on 8% or 10% polyacrylamide gels under nondenatur- 
ing conditions and the complexes detected by autoradiography. 
Polyribosomal and nuclear extracts were prepared as described 
previously and assayed under the same conditions (Pandey et al. 
1991). 
For the supershift assays on the myc-tagged polypeptides, 1 ~1 
of anti c-myc antibody (9El0, Oncogene Sciences) was added to 
each reaction after the initial incubation and the incubation was 
continued for 5 min at room temperature. 
In vitro processing 
A pre-mRNA containing the 3' end of the mouse histone H2a 
gene was used for the in vitro processing reactions. A synthetic 
pre-mRNA was synthesized using T7 RNA polymerase and la- 
beled with [ot-3Zp]CTP. Nuclear extracts were prepared from 
mouse myeloma cells as described previously and the process- 
ing reaction carried out for 30 min at 32~ exactly as described 
previously (Dominski et al. 1995). To deplete the SLBP from the 
nuclear extract, 10 ~1 of anti-SLBP IgG was added to 200 izl of 
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extract and the extract incubated on ice for 1 hr. Forty micro- 
liters of prewashed protein A-agarose beads were added to the 
extract and incubated on ice for 30 min. The protein A-agarose 
beads were removed by centrifugation at 2000 rpm for 3 min. 
The extract was collected and used for both mobility shift and 
RNA processing assays. 
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